ARTV
Price
$4.03
Change
+$0.16 (+4.13%)
Updated
Feb 6 closing price
Capitalization
98.92M
49 days until earnings call
Intraday BUY SELL Signals
JANX
Price
$13.07
Change
+$0.89 (+7.31%)
Updated
Feb 6 closing price
Capitalization
784.33M
25 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARTV vs JANX

Header iconARTV vs JANX Comparison
Open Charts ARTV vs JANXBanner chart's image
Artiva Biotherapeutics
Price$4.03
Change+$0.16 (+4.13%)
Volume$145.05K
Capitalization98.92M
Janux Therapeutics
Price$13.07
Change+$0.89 (+7.31%)
Volume$1.77M
Capitalization784.33M
ARTV vs JANX Comparison Chart in %
ARTV
Daily Signal:
Gain/Loss:
JANX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ARTV vs. JANX commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTV is a Hold and JANX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (ARTV: $4.03 vs. JANX: $13.07)
Brand notoriety: ARTV and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTV: 11% vs. JANX: 84%
Market capitalization -- ARTV: $98.92M vs. JANX: $784.33M
ARTV [@Biotechnology] is valued at $98.92M. JANX’s [@Biotechnology] market capitalization is $784.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTV’s FA Score shows that 1 FA rating(s) are green whileJANX’s FA Score has 1 green FA rating(s).

  • ARTV’s FA Score: 1 green, 4 red.
  • JANX’s FA Score: 1 green, 4 red.
According to our system of comparison, ARTV is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTV’s TA Score shows that 3 TA indicator(s) are bullish while JANX’s TA Score has 4 bullish TA indicator(s).

  • ARTV’s TA Score: 3 bullish, 4 bearish.
  • JANX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, JANX is a better buy in the short-term than ARTV.

Price Growth

ARTV (@Biotechnology) experienced а +3.60% price change this week, while JANX (@Biotechnology) price change was -4.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

ARTV is expected to report earnings on Mar 30, 2026.

JANX is expected to report earnings on Mar 06, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($784M) has a higher market cap than ARTV($98.9M). JANX YTD gains are higher at: -5.290 vs. ARTV (-6.061). ARTV has higher annual earnings (EBITDA): -83.6M vs. JANX (-142.22M). JANX has more cash in the bank: 989M vs. ARTV (123M). ARTV has less debt than JANX: ARTV (11.7M) vs JANX (22.7M). JANX has higher revenues than ARTV: JANX (10M) vs ARTV (0).
ARTVJANXARTV / JANX
Capitalization98.9M784M13%
EBITDA-83.6M-142.22M59%
Gain YTD-6.061-5.290115%
P/E RatioN/AN/A-
Revenue010M-
Total Cash123M989M12%
Total Debt11.7M22.7M52%
TECHNICAL ANALYSIS
Technical Analysis
ARTVJANX
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 19 days ago
86%
Bullish Trend 19 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARTV
Daily Signal:
Gain/Loss:
JANX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IPOIX24.570.54
+2.25%
Nomura Systematic Emerging Markets Eq I
JDPNX16.300.32
+2.00%
Janus Henderson Mid Cap Value N
GLBIX10.180.17
+1.70%
Leuthold Global Institutional
FIFVX26.280.44
+1.70%
Fidelity Advisor Founders I
FRURX24.470.14
+0.58%
Franklin Utilities R

ARTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTV has been closely correlated with QNCX. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARTV jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTV
1D Price
Change %
ARTV100%
+4.13%
QNCX - ARTV
94%
Closely correlated
-4.79%
MREO - ARTV
89%
Closely correlated
+13.20%
TPST - ARTV
89%
Closely correlated
+7.62%
CALC - ARTV
89%
Closely correlated
-1.77%
BDRX - ARTV
82%
Closely correlated
-4.62%
More

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been closely correlated with RZLT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if JANX jumps, then RZLT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+7.31%
RZLT - JANX
69%
Closely correlated
+6.85%
ARTV - JANX
67%
Closely correlated
+4.13%
VTGN - JANX
66%
Closely correlated
+11.52%
MREO - JANX
66%
Loosely correlated
+13.20%
ARCT - JANX
65%
Loosely correlated
+7.83%
More